Cutaneous glomangioma
disease diseaseOn this page
Also known as glomangioma of skinglomangioma of the skinskin glomangiomazone of skin glomangioma
Summary
Cutaneous glomangioma (MONDO:0002298) is a disease. A subtype of skin glomus tumor — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | cutaneous glomangioma |
| Mondo ID | MONDO:0002298 |
| DOID | DOID:2435 |
| ICD-11 | 1486488869 |
| NCIT | C6750 |
| SNOMED CT | 403970001 |
| UMLS | C1275226 |
| MedGen | 266155 |
| GARD | 0023110 |
| Anatomy (UBERON) | UBERON:0000014 |
| Is cancer (heuristic) | no |
Also known as: cutaneous glomangioma · glomangioma of skin · glomangioma of the skin · skin glomangioma · zone of skin glomangioma
Disease family
An umbrella term covering 1 Mondo subtype.
Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › skin neoplasm › dermis tumor › skin glomus tumor › cutaneous glomangioma
Related subtypes (2): subungual glomus tumor, cutaneous glomangiomyoma
Subtypes (1): telangiectatic glomangioma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.